Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 1 - 10 out of 54

CMS Request for Information: National Directory of Healthcare Providers & Services

December 6, 2022

The American Medical Informatics Association (AMIA) appreciates the opportunity to provide input to the Centers for Medicare and Medicaid Services (CMS) Request for Information: National Directory of Healthcare Providers & Services. AMIA commends CMS for soliciting input on the concept of establishing a National Directory of Healthcare Providers & Services […]

AMIA Lays Out Strategic Opportunities and Challenges for NLM

October 19, 2020

In comments delivered to the NIH’s National Library of Medicine (NLM), AMIA highlighted informatics-driven efforts to develop standards to facilities use of clinical data for research, foster computable and executable knowledge artifacts and a knowledge ecosystem, and advance how scholarly contributions are recognized. Beyond these efforts, AMIA encouraged NLM to […]

AMIA Supports More Research On Telemental Health

August 30, 2019

In response to a Request for Information from the National Institutes of Health (NIH), AMIA strongly supported additional research on whether telehealth can support initiatives related to suicide risk reduction and opioid overdose prevention. NIH was seeking input on current clinical experience in the use of telehealth in emergency department […]

AMIA Supports, Encourages Further Refinement of FDA AI/Machine Learning Regulatory Framework

June 5, 2019

In comments submitted this week to the U.S. Food and Drug Administration (FDA), the nation’s informatics professionals applauded the agency for developing a regulatory Modification Framework for Artificial Intelligence (AI)/Machine Learning (ML)-based software as a medical device (SaMD). The American Medical Informatics Association (AMIA) offered additional observations and recommendations for […]